We are thrilled to welcome Prof. Peled to our Board of Directors. His unparalleled expertise in cancer biology, stem cell mobilization, and therapeutic development will be invaluable as Silexion ...
Ori Biotech Ltd. (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, and Fresenius Kabi, an operating company of Fresenius, today announced a collaboration to integrate the IRO ® ...
Celltrion's asthma treatment is one step closer to a Canadian release, the drugmaker said Monday. The nation has greenlit Omlyclo — a biosimilar of, or lower-cost alternative to Novartis's Xolair — to ...
Kite, a Gilead Company , today announced findings from three new analyses for Yescarta® (axicabtagene ciloleucel) that demonstrate improved outcomes for people living with relapsed or refractory (R/R) ...